Cushman & Wakefield plc/$CWK
1D1W1MYTD1Y5YMAX
About Cushman & Wakefield plc
Cushman & Wakefield is a global commercial real estate services firm providing leasing, capital markets, property management, and project management to occupiers, owners, and investors across property types including office, industrial, retail, and data centers. The firm traces its roots back to 1917, where it was founded by brothers-in-law J. Clydesdale Cushman and Bernard Wakefield, and grew into its current form largely through a transformative 2015 merger with DTZ, a firm backed by TPG, PAG Asia Capital, and Ontario Teachers' Pension Plan. As of early 2026, the firm operates across roughly 400 offices in 60 countries with approximately 53,000 people.
- Ticker
- $CWK
- Sector
- Real Estate
- Primary listing
- NYSE
- Employees
- 53,000
- Headquarters
- Chicago, United States
- Website
- www.cushmanwakefield.com
CWK Metrics
BasicAdvanced
$3.2B
45.97
$0.30
1.44
-
Price and volume
Market cap
$3.2B
Beta
1.44
52-week high
$17.40
52-week low
$11.57
Average daily volume
1.7M
Financial strength
Current ratio
1.078
Quick ratio
0.997
Long term debt to equity
137.802
Total debt to equity
149.834
Interest coverage (TTM)
2.23%
Profitability
EBITDA (TTM)
581.8
Gross margin (TTM)
18.13%
Net profit margin (TTM)
0.64%
Operating margin (TTM)
4.41%
Effective tax rate (TTM)
31.38%
Revenue per employee (TTM)
$200,000
Management effectiveness
Return on assets (TTM)
3.94%
Return on equity (TTM)
3.52%
Valuation
Price to earnings (TTM)
45.972
Price to revenue (TTM)
0.294
Price to book
1.58
Price to tangible book (TTM)
-4.77
Price to free cash flow (TTM)
12.752
Free cash flow yield (TTM)
7.84%
Free cash flow per share (TTM)
1.071
Growth
Revenue change (TTM)
11.04%
Earnings per share change (TTM)
-65.88%
3-year revenue growth (CAGR)
3.29%
3-year earnings per share growth (CAGR)
56.31%
CWK News
AllArticlesVideos

Cushman & Wakefield Releases 2026 Data Center Development Cost Guide, Citing 21% Rise in Per-MW Construction Costs
Business Wire2 days ago

Cushman & Wakefield: U.S. Life Sciences Market Moves Toward Rebalancing as Capital Returns and New Development Slows
Business Wire5 days ago

Cushman & Wakefield Strengthens Capital Markets Platform with Addition of Loan Restructuring Expert Steve Klein
Business Wire2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.